Hudson Bay Capital Management’s Zura Bio Limited Warrants ZURAW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-199,575
Closed -$79.8K 1107
2024
Q2
$79.8K Sell
199,575
-400
-0.2% -$203 ﹤0.01% 672
2024
Q1
$54K Hold
199,975
﹤0.01% 612
2023
Q4
$86K Buy
+199,975
New +$86.3K ﹤0.01% 583
2023
Q2
Sell
-294,950
Closed -$73.8K 1020
2023
Q1
$73.8K Hold
294,950
﹤0.01% 670
2022
Q4
$44.2K Sell
294,950
-245,260
-45% -$24K ﹤0.01% 780
2022
Q3
$86K Sell
540,210
-49,689
-8% -$9.17K ﹤0.01% 946
2022
Q2
$106K Sell
589,899
-4,101
-0.7% -$1.11K ﹤0.01% 1029
2022
Q1
$255K Hold
594,000
﹤0.01% 904
2021
Q4
$273K Hold
594,000
﹤0.01% 887
2021
Q3
$356K Buy
+594,000
New +$346K ﹤0.01% 834

Hudson Bay Capital Management's ZURAW Position: Q3 2024 in Review

Hudson Bay Capital Management sold out of Zura Bio Limited Warrants (ZURAW) in Q3 2024, closing a stake of 199,575 shares — an estimated $79.8K sold.

Hudson Bay Capital Management first reported a position in ZURAW in Q3 2021 and held it in 10 quarters. The position peaked at $356K in Q3 2021. 0 funds tracked by Wall St. Rank hold ZURAW as of Q3 2024.

  • Hudson Bay Capital Management reported no remaining Zura Bio Limited Warrants position as of Q3 2024 after selling out during the quarter.
  • Hudson Bay Capital Management sold 199,575 Zura Bio Limited Warrants shares in Q3 2024, an estimated $79.8K.
  • Hudson Bay Capital Management first reported a position in Zura Bio Limited Warrants in Q3 2021 and held it in 10 quarters.
  • Hudson Bay Capital Management's Zura Bio Limited Warrants position peaked at $356K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Zura Bio Limited Warrants as of Q3 2024.

Based on Hudson Bay Capital Management's 13F filing for Q3 2024, filed 13 Nov 2024.